Alex Delaney-Gesing

Articles by Alex Delaney-Gesing

ASCRS 2020: Real-world efficacy of DEXYCU data retrospective case study

ByAlex Delaney-Gesing

May 17th 2020

ASCRS 2020: BVI traces business evolution, advent of pre-loaded product

ByAlex Delaney-Gesing

May 17th 2020

ASCRS 2020: Bio-Tissue posters focus on amniotic membrane

ByAlex Delaney-Gesing

May 17th 2020

ASCRS 2020: Assessing effectiveness of intracameral phenylephrine/ketorolac post-cataract surgery

ByAlex Delaney-Gesing

May 16th 2020

ASCRS 2020: Updates, improved injection technique from Eyepoint Pharmaceuticals

ByAlex Delaney-Gesing

May 16th 2020

ASCRS 2020: New solutions for patient, physician access from Sun Pharmaceuticals

ByAlex Delaney-Gesing

May 16th 2020

ASCRS 2020: Alcon research from biometer to trifocal to visualization

ByAlex Delaney-Gesing

May 16th 2020

ASCRS 2020: TearClear CEO shares company's vision, mission for future

ByAlex Delaney-Gesing

May 15th 2020

COVID-19: How Orbis International is managing operations

ByAlex Delaney-Gesing

May 9th 2020

COVID-19: Adapting patient care at Weill Cornell Medicine (New York)

ByAlex Delaney-Gesing

April 29th 2020

COVID-19: BELKIN Laser CEO offers company update

ByAlex Delaney-Gesing

April 17th 2020

Glaucoma 360: New developments in pharma (Ellie Chabi, MD; Santen, Inc)

ByAlex Delaney-Gesing

April 14th 2020

Glaucoma 360: Glaucoma devices update with Victor Chan, MB, MS (Santen Inc)

ByAlex Delaney-Gesing

April 13th 2020

COVID-19: How neuro-ophthalmology is acclimating in the pandemic era

ByAlex Delaney-Gesing

April 9th 2020

COVID 19: Tips for protecting patients/staff

ByAlex Delaney-Gesing

April 8th 2020

COVID-19: Putting safety measures into practice

ByAlex Delaney-Gesing

April 3rd 2020

COVID-19: Impact of pandemic on Switzerland's ophthalmic space

ByAlex Delaney-Gesing

April 2nd 2020

COVID-19: Business update on Novartis operations

ByAlex Delaney-Gesing

April 1st 2020

COVID-19: Life in the time of coronavirus

ByAlex Delaney-Gesing

March 30th 2020

COVID 19: How life/work has changed for German ophthalmologists

ByAlex Delaney-Gesing

March 26th 2020

COVID-19: German ophthalmologists respond to coronavirus impact

ByAlex Delaney-Gesing

March 25th 2020

COVID-19: Adapting patient services during a pandemic

ByAlex Delaney-Gesing

March 20th 2020

COVID-19: Ophthalmologists' perspective

ByAlex Delaney-Gesing

March 19th 2020

Glaucoma 360: Getting updated with Glauconix Biosciences

ByAlex Delaney-Gesing

March 12th 2020

John Berdahl, MD: I have an idea ... now what?

ByAlex Delaney-Gesing ,Sheryl Stevenson

February 18th 2020

Defining alternative therapies for glaucoma

BySheryl Stevenson,Alex Delaney-Gesing

February 9th 2020

Adrienne Graves, PhD, and Andrew Iwach, MD

Glaucoma 360 shines spotlight on innovation

BySheryl Stevenson,Alex Delaney-Gesing

February 8th 2020

Leveraging social media to expand keratoconus awareness

ByAlex Delaney-Gesing

December 12th 2019

How to implement IPL into your practice

ByAlex Delaney-Gesing

November 30th 2019

Energy-fluidics from cloud-based database for phacoemulsification

ByAlex Delaney-Gesing

November 26th 2019

Alex Delaney-Gesing

Articles by Alex Delaney-Gesing

ASCRS 2020: Real-world efficacy of DEXYCU data retrospective case study

ASCRS 2020: BVI traces business evolution, advent of pre-loaded product

ASCRS 2020: Bio-Tissue posters focus on amniotic membrane

ASCRS 2020: Assessing effectiveness of intracameral phenylephrine/ketorolac post-cataract surgery

ASCRS 2020: Updates, improved injection technique from Eyepoint Pharmaceuticals

ASCRS 2020: New solutions for patient, physician access from Sun Pharmaceuticals

ASCRS 2020: Alcon research from biometer to trifocal to visualization

ASCRS 2020: TearClear CEO shares company's vision, mission for future

COVID-19: How Orbis International is managing operations

COVID-19: Adapting patient care at Weill Cornell Medicine (New York)

COVID-19: BELKIN Laser CEO offers company update

Glaucoma 360: New developments in pharma (Ellie Chabi, MD; Santen, Inc)

Glaucoma 360: Glaucoma devices update with Victor Chan, MB, MS (Santen Inc)

COVID-19: How neuro-ophthalmology is acclimating in the pandemic era

COVID 19: Tips for protecting patients/staff

COVID-19: Putting safety measures into practice

COVID-19: Impact of pandemic on Switzerland's ophthalmic space

COVID-19: Business update on Novartis operations

COVID-19: Life in the time of coronavirus

COVID 19: How life/work has changed for German ophthalmologists

COVID-19: German ophthalmologists respond to coronavirus impact

COVID-19: Adapting patient services during a pandemic

COVID-19: Ophthalmologists' perspective

Glaucoma 360: Getting updated with Glauconix Biosciences

John Berdahl, MD: I have an idea ... now what?

Defining alternative therapies for glaucoma

Glaucoma 360 shines spotlight on innovation

Leveraging social media to expand keratoconus awareness

How to implement IPL into your practice

Energy-fluidics from cloud-based database for phacoemulsification

Trending on Ophthalmology Times - Clinical Insights for Eye Specialists

Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial

4DMT and Otsuka Pharmaceutical partner on 4D-150 in the greater Asia-Pacific region

AAVantgarde Bio closes $141 million Series B financing round

Viridian Therapeutics submits Biologics License Application to FDA for veligrotug